Understanding APC | malecare.org

Enzalutamide (Xtandi) Improves The Quality of Life As Well As Extending Life In Men With Castrate Resistant Prostate Cancer

In clinical trials Enzalutamide (Xtandi) significantly increased the overall survival and radiographic progression-free survival of men when compared with placebo. The trial, called PREVAIL evaluated men who were asymptomatic and minimally symptomatic, chemotherapy-naive with metastatic castration-resistant prostate cancer. The researchers expanded the data analysis and evaluated the effect of Xtandi on the men’s health-related quality [...]

By Malecare|2020-02-04T11:37:28-05:00June 12th, 2015|Advanced Prostate Cancer, enzalutamide, Uncategorized, Understanding APC, Xtandi|0 Comments

How Men Can Preserve Their Emotional Well Being When Fighting Advanced Prostate Cancer -Ideas For Interventions

In a study performed in the UK researchers explored how men with advanced prostate cancer support their personal well being. The study analyzed the practices used by five (5) men with advanced prostate cancer to maintain their emotional wellbeing. Information about the men’s individual practices was taken from face-to-face, semi-structured, in-depth interviews with the five [...]

By Malecare|2020-02-04T11:37:32-05:00June 9th, 2015|Advanced Prostate Cancer, advanced prostate cancer support group, How We Live, mental health, Research, survivorship, Uncategorized, Understanding APC|2 Comments

More On The Efficacy Of Sipuleucel-T (Provenge) – It Works

Despite its approval five years ago sipuleucel-T (Provenge) remains one of the most controversial treatments available for men with castrate resistant metastatic prostate cancer (mCRPC). Provenge has its advocates (Full Disclosure- I am) and it has many detractors. The detractors argue that it doesn’t work and they hang their hat on the argument that it [...]

By Malecare|2020-02-04T11:45:00-05:00April 7th, 2015|Advanced Prostate Cancer, Drugs & Treatments, immunotherapy, Provenge, Uncategorized, Understanding APC|5 Comments

Lethal Advanced Prostate Cancer Has Inherently Heterogeneity And Can Spread From Other Metastatic Sites

We still have a lot to learn about how prostate cancer actually spreads, or metastasizes. Current theory holds that the primary tumor is probably most responsible for the development of distant metastases. In a new genomic analysis of tissue performed at the Johns Hopkins University using tissue from prostate cancer patients this paradigm has been [...]

By Malecare|2020-02-04T11:15:49-05:00April 2nd, 2015|Advanced Prostate Cancer, Drugs & Treatments, genetics, Metastases, Uncategorized, Understanding APC|0 Comments

Controversy at ASCO GU: Conflicting Randomized Trials on Docetaxel Plus ADT for Hormone Sensitive Metastatic Prostate Cancer *

Last year after the ASCO meeting in Chicago I declared that there was one particular presentation of the CHAARTED trial that would be a game changer for the treatment of newly diagnosed men with very significant prostate cancer. The game changer was that men diagnosed with significant disease and who were still ADT naive (not [...]

By Malecare|2020-02-04T10:39:13-05:00April 1st, 2015|Advanced Prostate Cancer, ASCO, Chemo Therapy, Clinical Trials, Clinical Trials, Drugs & Treatments, Hormone Therapy, taxotere, Uncategorized, Understanding APC|0 Comments